We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Amid Health Concerns, FDA Reviews Safety of Several Heavily Used Anemia Drugs.
- Authors
Tuma, Rabiya S.
- Abstract
The article reports that the U.S. Food and Drug Administration (FDA) has reviewed the safety for anemia drugs. It mentioned that the FDA has added the highest level of warning to the label of three erythropoiesis-stimulating agents (ESA). For it shows a higher risk of heart attacks or death if their target hemoglobin was above a certain level for those patients taking the ESA.
- Subjects
UNITED States; DRUG interactions; ERYTHROPOIESIS; HEART diseases; BLOOD diseases; ANEMIA; PHYSIOLOGICAL control systems; UNITED States. Food &; Drug Administration
- Publication
JNCI: Journal of the National Cancer Institute, 2007, Vol 99, Issue 10, p746
- ISSN
0027-8874
- Publication type
Article
- DOI
10.1093/jnci/djk216